razoxane has been researched along with Lymphoma in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (80.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Finch, M; Hellmann, K; Hutchinson, GE; Li, XT; Pym, BA | 1 |
| Bruno, S; Macdonald, JS; Marsoni, S; Penta, J; Poster, DS | 1 |
| Begg, CB; Glick, JH; O'Connell, MJ; Oken, MM; Silverstein, MN | 1 |
| Kizaki, H; Onishi, Y | 1 |
| Clarke, JJ; Dunkel, VC; San, RH; Seifried, HE; Whittaker, P | 1 |
| Bateman, JR; Corder, MP; Flannery, EP; Pajak, TF; Sheehan, WW | 1 |
| Bellet, RE; Muggia, FM; Penta, JS; Rozencweig, M; Von Hoff, DD; Wasserman, TH | 1 |
| Das, S; Garrett, MJ | 1 |
| Hammershaimb, LD; Hurson, SB; Marsoni, S; Simon, RM; Ungerleider, RS | 1 |
| Harper, JI; Langtry, JA; Mallett, RB; Staughton, RC | 1 |
3 trial(s) available for razoxane and Lymphoma
| Article | Year |
|---|---|
Bis-diketopiperazine derivatives in clinical oncology: ICRF-159.
Topics: Animals; Antineoplastic Agents; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Drug Evaluation; Drug Interactions; Head and Neck Neoplasms; Humans; Lymphoma; Mice; Neoplasm Metastasis; Neoplasms; Piperazines; Razoxane | 1980 |
Randomized clinical trial comparing two dose regimens of ICRF-159 in refractory malignant lymphomas.
Topics: Adult; Aged; Clinical Trials as Topic; Female; Hodgkin Disease; Humans; Leukopenia; Lymphoma; Male; Middle Aged; Myeloproliferative Disorders; Piperazines; Probability; Prognosis; Razoxane; Thrombocytopenia | 1980 |
Phase II study of ICRF-159 in non-Hodgkin's lymphomas.
Topics: Adult; Aged; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Lymphoma; Male; Middle Aged; Piperazines; Razoxane | 1978 |
7 other study(ies) available for razoxane and Lymphoma
| Article | Year |
|---|---|
Effect of AT1727 on growth and metastasis of murine tumours.
Topics: Animals; Antineoplastic Agents; Drug Administration Schedule; Female; Leukemia L1210; Lung Neoplasms; Lymphoma; Male; Melanoma; Mice; Neoplasm Metastasis; Neoplasms, Experimental; Piperazines; Razoxane; Sarcoma 180 | 1983 |
Topoisomerase II inhibitor-induced apoptosis in thymocytes and lymphoma cells.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; Apoptosis; Base Sequence; Cell Cycle; Cells, Cultured; DNA Fragmentation; DNA Topoisomerases, Type II; Enzyme Inhibitors; Etoposide; Gene Expression Regulation; Heterogeneous Nuclear Ribonucleoprotein A1; Heterogeneous-Nuclear Ribonucleoprotein Group A-B; Heterogeneous-Nuclear Ribonucleoproteins; Lymphoma; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Razoxane; Ribonucleoproteins; T-Lymphocytes; Thymus Gland; Topoisomerase II Inhibitors | 1997 |
Genotoxicity of iron chelators in L5178Y mouse lymphoma cells.
Topics: Animals; Deferiprone; Edetic Acid; Iron Chelating Agents; Lymphoma; Mice; Mutagenicity Tests; Phenanthrolines; Pyridones; Razoxane; Tumor Cells, Cultured | 2001 |
ICRF-159: current status and clinical prospects.
Topics: Alopecia; Animals; Colonic Neoplasms; Humans; Leukopenia; Lung Neoplasms; Lymphoma; Melanoma; Mice; Nausea; Neoplasms, Experimental; Piperazines; Razoxane; Rectal Neoplasms; Sarcoma | 1977 |
Treatment of the lymphomata with ICRF 159 (NSC 129943) adjunctive to combination chemotherapy.
Topics: Antineoplastic Agents; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lymphoma; Male; Piperazines; Razoxane | 1977 |
Tolerance to antineoplastic agents in children and adults.
Topics: Adult; Ancitabine; Antineoplastic Agents; Child; Dose-Response Relationship, Drug; Drug Evaluation; Drug Tolerance; Humans; Hypotension; Leukemia; Lymphoma; Neoplasms; Posture; Razoxane; Retrospective Studies | 1985 |
Psoriasis, razoxane and a cutaneous B-cell lymphoma.
Topics: Aged; B-Lymphocytes; Female; Humans; Lip Neoplasms; Lymphoma; Piperazines; Psoriasis; Razoxane | 1987 |